AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,542 | +10.6% | 37,231 | 0.0% | 0.00% | – |
Q3 2022 | $24,000 | -31.4% | 37,231 | 0.0% | 0.00% | – |
Q2 2022 | $35,000 | -68.8% | 37,231 | -55.7% | 0.00% | – |
Q1 2022 | $112,000 | -70.2% | 84,117 | -13.7% | 0.00% | – |
Q4 2021 | $376,000 | -26.7% | 97,485 | +6.1% | 0.00% | – |
Q3 2021 | $513,000 | -76.8% | 91,882 | -63.0% | 0.00% | -100.0% |
Q2 2021 | $2,209,000 | -21.0% | 248,394 | +12.7% | 0.00% | 0.0% |
Q1 2021 | $2,797,000 | -9.2% | 220,346 | -0.3% | 0.00% | 0.0% |
Q4 2020 | $3,081,000 | +17.8% | 220,962 | +10.0% | 0.00% | 0.0% |
Q3 2020 | $2,616,000 | -17.5% | 200,868 | +10.6% | 0.00% | -50.0% |
Q2 2020 | $3,170,000 | +34.6% | 181,654 | +20.0% | 0.00% | +100.0% |
Q1 2020 | $2,356,000 | -11.1% | 151,402 | +15.1% | 0.00% | 0.0% |
Q4 2019 | $2,649,000 | +43.1% | 131,557 | +0.4% | 0.00% | 0.0% |
Q3 2019 | $1,851,000 | +99.2% | 131,080 | +129.4% | 0.00% | 0.0% |
Q2 2019 | $929,000 | -4.8% | 57,134 | +29.1% | 0.00% | 0.0% |
Q1 2019 | $976,000 | +78.8% | 44,253 | +35.1% | 0.00% | – |
Q4 2018 | $546,000 | -68.5% | 32,767 | -2.0% | 0.00% | -100.0% |
Q3 2018 | $1,735,000 | – | 33,434 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,191,676 | $16,612,000 | 8.00% |
Aisling Capital Management LP | 1,009,779 | $14,076,000 | 2.42% |
Burrage Capital Management LLC | 145,715 | $2,031,000 | 1.55% |
Camber Capital Management LP | 3,133,333 | $43,679,000 | 1.53% |
New Leaf Venture Partners, L.L.C. | 315,550 | $4,399,000 | 1.02% |
SPHERA FUNDS MANAGEMENT LTD. | 655,874 | $9,143,000 | 0.81% |
EMERALD ADVISERS, LLC | 1,009,212 | $14,068,000 | 0.47% |
Penn Mutual Asset Management, LLC | 37,306 | $520,000 | 0.46% |
EMERALD MUTUAL FUND ADVISERS TRUST | 932,627 | $13,001,000 | 0.45% |
MPM BioImpact LLC | 364,285 | $5,078,000 | 0.44% |